DESCRIPTION

• Shiptemp: -80°C (dry ice)
• Synonyms: Cytotoxic T-lymphocyte-associated protein 4 CD152, T-lymphocyte activation antigen CD86, B7.2, FUN-1, B70, BU63, CD86, B72
• Warnings: Avoid freeze/thaw cycles.
• Category: Immunotherapy/Assay Kit
• Background: B7-2 (CD86) signaling through CTLA4 (CD152) has been shown to inhibit T- cell activation. This co-inhibitory pathway can be overactive in many tumors, enabling cancers to escape the host's immune system. CTLA4-blocking antibodies, including Ipilimumab (Yervoy) and Tremelimumab, have shown clinical efficacy in treating cancer.
• References: 1. Ohtani, H., et al., Lab Invest. 1997; 77(3): 231-241. 2. Robert, C., et al., N. Engl. J. Med. 2011; 364: 2517-2526.
• Description: The CTLA4:B7-2[Biotinylated] Inhibitor Screening Assay Kit is designed for screening and profiling inhibitors of CTLA4:B7-2-biotin interaction. The key to this kit is the high sensitivity of detection of CTLA4 by streptavidin-HRP. Only a few simple steps on a microtiter plate are required for the assay. First, CTLA4 is coated on a 96-well plate. Next, B7-2-biotin is incubated with CTLA4 on the plate. Finally, the plate is treated with streptavidin-HRP followed by addition of an HRP substrate to produce chemiluminescence, which can then be measured using a chemiluminescence reader.
• Methodology: Chemiluminescent
• Supplied As: This kit comes in a convenient 96-well format, with CTLA4 (CD152), purified biotin-labeled B7-2 (CD86), streptavidin-labeled HRP, and assay buffer for 100 binding reactions.
• Unspsc Code: 41121811
• Unspsc Name: Laboratory microchemistry kits
• Applications: This kit is useful for screening for inhibitors of CTLA4 binding to B7-2.
• Product Type: Assay Kit
• Biosafety Level: Not applicable (BSL-1)
• Related Products: 72009, 79515, 79572, 79512
• Storage Stability: One year from date of receipt when stored as directed.
• Scientific Category: Immunotherapy/Cell Surface Receptor
• Instructions for Use: See assay kit datasheet for detailed protocol.